Authorities in the U.S. and Europe are reviewing applications from Vertex Pharmaceuticals seeking approval of the company’s novel CFTR…
Articles by Marisa Wexler, MS
During pulmonary exacerbation in cystic fibrosis (CF), bacterial communities in the lungs tend to change in one of two…
Two Massachusetts-based companies, Nanite and Saliogen Therapeutics, are teaming up on a new research project that aims to…
This year’s “Fishing for a Cure,” an annual fundraiser hosted by Constellation Energy Corporation, has raised $70,000 for the…
Evoq Bio said it successfully completed a meeting with the U.S. Food and Drug Administration (FDA), held to discuss the…
Phage therapy, a promising strategy for treating antibiotic-resistant lung infections that’s currently in clinical trials, can trigger the release of…
Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) helps increase fat stores in adults with cystic fibrosis (CF), especially those who are…
Infections of Pseudomonas aeruginosa usually persist in people with cystic fibrosis (CF) after Trikafta is started, a…
A test of physical function called Glittre-ADL may be better than the standard six-minute walk test at identifying physical limitations…
Treatment with Trikafta (ivacaftor/tezacaftor/elexacaftor) eases nose and sinus symptoms in eligible patients with cystic fibrosis (CF), and the…